Analyst Says Henry Schein 2023 Guidance Encouraging But Still Impacted By Headwinds
Henry Schein Inc (NASDAQ:HSIC) posts Q4 FY22 sales of $3.37 billion, beating the consensus of $3.34 billion. The 1.2% increase…
Henry Schein Expects FY23 Adjusted EPS of $5.25-$5.42 Vs. 4.95 Estimate
2023 sales growth is expected to be approximately 1% to 3% over 2022.
2023 sales of PPE products and COVID-19 test kits are expected to decrease in aggregate by
Earnings Scheduled For February 16, 2023
Companies Reporting Before The Bell
• RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022.
• Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year 2022.
Piper Sandler Maintains Overweight on Henry Schein, Raises Price Target to $97
Piper Sandler analyst Jason Bednar maintains Henry Schein (NASDAQ:HSIC) with a Overweight and raises the price target from $85 to $97.
Cramer On This Stock Down 5% In Last Month: ‘It’s Very Plain Vanilla’
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Entegris Inc (NASDAQ: ENTG).
Morgan Stanley Maintains Underweight on Henry Schein, Lowers Price Target to $70
Morgan Stanley analyst Erin Wright maintains Henry Schein (NASDAQ:HSIC) with a Underweight and lowers the price target from $72 to $70.
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Looking Into Henry Schein’s Return On Invested Capital
According to Benzinga Pro data Henry Schein (NASDAQ:HSIC) posted a 2.99% decrease in earnings from Q2. Sales, however, increased by 1.22% over the previous quarter to $3.07 billion.
Henry Schein Discloses Receipt Of 2 Subpoenas From U.S. Attorney’s Office For The Western District Of Virginia
- SEC Filing
Inline XBRL Viewer (sec.gov)
Piper Sandler Maintains Overweight on Henry Schein, Lowers Price Target to $85
Piper Sandler analyst Jason Bednar maintains Henry Schein (NASDAQ:HSIC) with a Overweight and lowers the price target from $96 to $85.